Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 1544

Sort by

Sort Order Select

Journal Articles

Vitamin K antagonists did not increase the risk of myelodysplastic syndrome in a large-scale cohort study

Anke Neumann, Marie-Joelle Jabagi, Mahmoud Zureik

Blood (2021) 138 (5): 417–420.

https://doi.org/10.1182/blood.2021010848

Published: 2021

Includes: Supplemental data

Journal Articles

Prothrombotic immune thrombocytopenia after COVID-19 vaccination

Andreas Tiede, Ulrich J. Sachs, Andreas Czwalinna, Sonja Werwitzke, Rolf Bikker, Joachim K. Krauss, Frank Donnerstag, Karin Weißenborn, Günter Höglinger, Benjamin Maasoumy, Heiner Wedemeyer, Arnold Ganser

Blood (2021) 138 (4): 350–353.

https://doi.org/10.1182/blood.2021011958

Published: 2021

Includes: Supplemental data

Journal Articles

Ignoring instead of chasing after coagulation factor VII during warfarin management: an interrupted time series study

Alma R. Oskarsdottir, Brynja R. Gudmundsdottir, Hulda M. Jensdottir, Bjorn Flygenring, Ragnar Palsson, Pall T. Onundarson

Blood (2021) 137 (20): 2745–2755.

https://doi.org/10.1182/blood.2020008698

Published: 2021

Includes: Supplemental data

Journal Articles

Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry

Blood (2021) 137 (20): 2838–2847.

https://doi.org/10.1182/blood.2020010529

Published: 2021

Includes: Supplemental data

Journal Articles

Reduced expression of annexin A2 is associated with impaired cell surface fibrinolysis and venous thromboembolism

Hannah Fassel, Huigen Chen, Mary Ruisi, Neha Kumar, Maria DeSancho, Katherine A. Hajjar

Blood (2021) 137 (16): 2221–2230.

https://doi.org/10.1182/blood.2020008123

Published: 2021

Includes: Supplemental data

Journal Articles

Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis

Emanuele Valeriani, Marcello Di Nisio, Nicoletta Riva, Omri Cohen, Juan-Carlos Garcia-Pagan, Marta Magaz, Ettore Porreca, Walter Ageno

Blood (2021) 137 (9): 1233–1240.

https://doi.org/10.1182/blood.2020006827

Published: 2021

Includes: Supplemental data

Journal Articles

Another front in COVID-19’s perfect storm

Shawn M. Jobe, Renren Wen

Blood (2021) 137 (8): 1006–1007.

https://doi.org/10.1182/blood.2020010459

Published: 2021

Journal Articles

How I treat unexplained arterial thrombosis

Jori E. May, Stephan Moll

Blood (2020) 136 (13): 1487–1498.

https://doi.org/10.1182/blood.2019000820

Published: 2020

Journal Articles

Postdischarge thrombosis and hemorrhage in patients with COVID-19

Rushad Patell, Thomas Bogue, Anita Koshy, Poorva Bindal, Mwanasha Merrill, William C. Aird, Kenneth A. Bauer, Jeffrey I. Zwicker

Blood (2020) 136 (11): 1342–1346.

https://doi.org/10.1182/blood.2020007938

Published: 2020

Includes: Supplemental data

Journal Articles

Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study

Douglas Tremblay, Maaike van Gerwen, Mathilda Alsen, Santiago Thibaud, Alaina Kessler, Sangeetha Venugopal, Iman Makki, Qian Qin, Sirish Dharmapuri, Tomi Jun, Sheena Bhalla, Shana Berwick, Jonathan Feld, John Mascarenhas, Kevin Troy, Caroline Cromwell, Andrew Dunn, William K. Oh, Leonard Naymagon

Blood (2020) 136 (1): 144–147.

https://doi.org/10.1182/blood.2020006941

Published: 2020

Includes: Supplemental data

Journal Articles

COVID-19 and its implications for thrombosis and anticoagulation

Jean M. Connors, Jerrold H. Levy

Blood (2020) 135 (23): 2033–2040.

https://doi.org/10.1182/blood.2020006000

Published: 2020

Journal Articles

Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease

Erica M. Sparkenbaugh, Chunsheng Chen, Tomasz Brzoska, Julia Nguyen, Shaobin Wang, Gregory M. Vercellotti, Nigel S. Key, Prithu Sundd, John D. Belcher, Rafal Pawlinski

Blood (2020) 135 (20): 1783–1787.

https://doi.org/10.1182/blood.2019003543

Published: 2020

Includes: Multimedia, Supplemental data

Journal Articles

How I treat obese patients with oral anticoagulants

Tzu-Fei Wang, Marc Carrier

Blood (2020) 135 (12): 904–911.

https://doi.org/10.1182/blood.2019003528

Published: 2020

Journal Articles

Managing thromboembolic risk in patients with hereditary and acquired thrombophilias

Jason Moran, Kenneth A. Bauer

Blood (2020) 135 (5): 344–350.

https://doi.org/10.1182/blood.2019000917

Published: 2020

Journal Articles

Acute treatment of venous thromboembolism

Cecilia Becattini, Giancarlo Agnelli

Blood (2020) 135 (5): 305–316.

https://doi.org/10.1182/blood.2019001881

Published: 2020

Journal Articles

Treatment of unusual thrombotic manifestations

Maria Abbattista, Marco Capecchi, Ida Martinelli

Blood (2020) 135 (5): 326–334.

https://doi.org/10.1182/blood.2019000918

Published: 2020

Journal Articles

Treatment of venous thromboembolism in pediatric patients

Char Witmer, Leslie Raffini

Blood (2020) 135 (5): 335–343.

https://doi.org/10.1182/blood.2019001847

Published: 2020

Journal Articles

Long-term treatment of venous thromboembolism

Clive Kearon, Susan R. Kahn

Blood (2020) 135 (5): 317–325.

https://doi.org/10.1182/blood.2019002364

Published: 2020

Journal Articles

Low FV beneficial in FVFVIII deficiency?

Björn Dahlbäck

Blood (2019) 134 (20): 1686–1688.

https://doi.org/10.1182/blood.2019003243

Published: 2019

Journal Articles

Venous-Thromboembolism in Elderly Patients with Acute Myeloid Leukemia

Radhika Gangaraju, MD, Smita Bhatia, MDMPH, Kelly Kenzik, PhD

Blood (2019) 134 (Supplement_1): 4679.

https://doi.org/10.1182/blood-2019-124464

Published: 2019

NARROW

Vitamin K antagonists did not increase the risk of myelodysplastic syndrome in a large-scale cohort study

Prothrombotic immune thrombocytopenia after COVID-19 vaccination

Ignoring instead of chasing after coagulation factor VII during warfarin management: an interrupted time series study

Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry

Reduced expression of annexin A2 is associated with impaired cell surface fibrinolysis and venous thromboembolism

Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis

Another front in COVID-19’s perfect storm

How I treat unexplained arterial thrombosis

Postdischarge thrombosis and hemorrhage in patients with COVID-19

Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study

COVID-19 and its implications for thrombosis and anticoagulation

Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease

How I treat obese patients with oral anticoagulants

Managing thromboembolic risk in patients with hereditary and acquired thrombophilias

Acute treatment of venous thromboembolism

Treatment of unusual thrombotic manifestations

Treatment of venous thromboembolism in pediatric patients

Long-term treatment of venous thromboembolism

Low FV beneficial in FVFVIII deficiency?

Venous-Thromboembolism in Elderly Patients with Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only